Ypsomed AB – Finnland

Allgemeine Informationen

The Ypsomed Group is a leading independent developer and manufacturer of injection systems for self-medication and a well-known diabetes specialist with more than 25 years’ experience. The Ypsomed Group, which emerged in 2003 from the Disetronic Group, offers insulin pumps, injection systems and pen needles for diabetes, growth hor-mone and infertility treatments as well as for other therapeutic purposes.

Address: Brunnmattstrasse 6, 3401 Burgdorf, Switzerland

Ypsomed is an innovation and technology leader with an extensive patent portfolio and is the preferred partner of pharmaceutical and biotech companies in the self-medication sector. Ypsomed has established itself as a leading provider of brand, co-branding and OEM products in the retail and business-to-business segments. Ypsomed is also deeply committed to advances in patient care.

Under the mylife™ Diabetescare brand, Ypsomed provides patients with the products it manufactures or distributes. The Ypsomed Group has its headquarters in Burgdorf, Switzerland. It has several manufacturing sites in Switzerland as well as leading independent diabetes product sales companies throughout Europe.